Cookies are required to ensure that the best use of our resources HCV jestem świadom. They store information about your preferences and other information to help us improve our website. None of this information will not be used to identify you. You can find out more about cookies and how to control them using the settings in your web browser with cookies guide.

Project 2 - Aim and expected results/outcomes


  • To reduce risk of HCV infection in the population of injecting drug users (IDUs)


  • To cover IDUs population by evidence based HCV prevention measures
  • To increase institutional capacity to response HCV problem among IDUs

Expected results/outcomes:

  • Prevention and treatment needs assessed by estimation of HCV prevalence in IDUs population and identification of risk and protective factors
  • Products’ developments:
    • National HCV Prevention and Control Strategy for the years 2015-2020 focused on IDUs elaborated
    • Model HCV prevention program targeting IDUs developed
  • Model HCV prevention program targeting IDUs evaluated
  • Model HCV prevention program targeting IDUs disseminated
Counter: 49821